Delta-8 THCp and Delta-9 THCp

THCp, or tetrahydrocannabiphorol, is a recently discovered cannabinoid found in the cannabis plant. It was first identified in a 2019 study conducted by Italian researchers who analyzed the chemical composition of a specific cannabis strain. THCp is a homolog of THC (tetrahydrocannabinol), the primary psychoactive compound in cannabis, meaning they have similar chemical structures but with some key differences.

The primary distinction between THC and THCp is the presence of a longer side chain in THCp’s molecular structure. This difference affects the way THCp interacts with the body’s endocannabinoid system, specifically the CB1 and CB2 receptors, which play a role in the psychoactive effects of cannabis.

Initial research on THCp suggests that it may be significantly more potent than THC, with binding affinity for the CB1 receptor up to 33 times stronger than that of THC. However, it is essential to note that research on THCp is still in its early stages, and more studies are needed to confirm these findings and understand the specific effects and potential therapeutic applications of THCp.

As our understanding of cannabinoids continues to grow, future research may provide more information on THCp’s properties, effects, and potential uses in medical and recreational contexts.